SEC 13F Intelligence

Rk Capital Management, LLC / AMED

Rk Capital Management, LLC’s Amedisys Inc Position

Does Rk Capital Management, LLC own Amedisys Inc (AMED)? Not currently — the last reported position was 77.5K shares worth $8M in Q2 2022; the fund’s latest 13F (Q3 2024) no longer reports it.

Position Value
$8M
Q2 2022
Shares
77.5K
% of Portfolio
+1.92%
Quarters Held
2
position exited

Position History AMED

Reported value by quarter
Q1 ’22: $9MQ1 ’22Q2 ’22: $8MQ2 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202277.5K$8M+1.92%
Q1 202254.9K$9M+1.86%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rk Capital Management, LLC’s full portfolio or all institutional holders of AMED.